Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa.
about
Corticosteroids for acute bacterial meningitisOsmotic therapies added to antibiotics for acute bacterial meningitisCorticosteroids for acute bacterial meningitisOsmotic therapies as adjuncts to antibiotics for acute bacterial meningitisCorticosteroids for acute bacterial meningitisDefense at the border: the blood-brain barrier versus bacterial foreignersPathophysiology and treatment of bacterial meningitisAdjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient dataPathogen recognition and inflammatory signaling in innate immune defensesCorticosteroid administration and outcome of adolescents and adults with acute bacterial meningitis: a meta-analysisLATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITYMeta-analysis of studies comparing adjuvant dexamethasone to glycerol to improve clinical outcome of bacterial meningitisHIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited SettingsCost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South AfricaEpidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis.Burden of disease in adults admitted to hospital in a rural region of coastal Kenya: an analysis of data from linked clinical and demographic surveillance systemsAdult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected casesCombination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in MalawiBacterial Meningitis in Patients using Immunosuppressive Medication: a Population-based Prospective Nationwide StudyTen years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi.A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adultsScreening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxisPrevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency MedicineDesign, data analysis and sampling techniques for clinical research.Validation of a Dutch risk score predicting poor outcome in adults with bacterial meningitis in Vietnam and Malawi.Cost-effective diagnostic checklists for meningitis in resource-limited settings.Genomic pneumococcal load and CSF cytokines are not related to outcome in Malawian adults with meningitis.Recognising and treatment seeking for acute bacterial meningitis in adults and children in resource-poor settings: a qualitative study.High mortality amongst adolescents and adults with bacterial meningitis in sub-Saharan Africa: an analysis of 715 cases from MalawiCryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial.Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.Immunological and biochemical correlates of adjunctive dexamethasone in Vietnamese adults with bacterial meningitisEvaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitisEpstein-barr virus coinfection in cerebrospinal fluid is associated with increased mortality in Malawian adults with bacterial meningitis.Neuro-intensive care of patients with acute CNS infections.Persistence of pneumolysin in the cerebrospinal fluid of patients with pneumococcal meningitis is associated with mortalityDeath is associated with complement C3 depletion in cerebrospinal fluid of patients with pneumococcal meningitis.Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis.
P2860
Q24187220-EB08E595-4A80-49DC-9029-593D7D21ACC6Q24198273-AFDBBEE9-5877-4602-9567-4157A2630B95Q24202288-78D997B8-3E34-41B9-9EFD-AFA7FB686DCEQ24234181-A1952465-B7B3-4DE8-981D-4B052D9D9C85Q24235514-39FEE7B0-79CF-4894-925A-573E686036DFQ24610752-BCEC9572-BBD0-4FF4-9331-2DDF3553B8D9Q24628983-610A958C-5879-4C0F-93C0-33DDEFBADA9CQ24630702-EEF77A7E-DF46-4D91-84C8-0B446F2522E3Q24643034-80C5BBCC-3FDE-4589-A324-273925C1FF54Q24651532-243A487D-04FD-43AE-9F88-9F71EC6A669AQ26783210-595E25BC-0672-43FC-81B1-C4C2FB2982D5Q28074761-B49BB7B8-5CF7-4935-B310-A44D4ADBE94FQ28078958-9AA4E603-8E92-4AF1-B8F9-5C3E090F57F6Q28534733-112EBBA4-82DD-4C17-ACBE-FEF8D93952EAQ30431534-AE62B844-2F1B-400A-85BC-5F3003550106Q30655904-85F376EB-9691-4AB6-9869-FF7E345A4C4DQ30811807-A34721CC-5646-4640-981F-76674868D9F4Q33540873-805878D0-4B75-4E58-97C0-E7079EE46474Q33588561-5D5D5E7E-3033-4532-B5BC-DEE32F3B61E7Q33603327-B159037D-658D-4080-AF61-F064D99B97BEQ33851271-7A04B5CE-0D8F-4BF5-8F04-C8604A08C413Q33864631-E7654659-978C-4D68-9D96-C7EA9473DA76Q33871884-60C3576F-1713-435A-AAD7-AF2B30D63252Q33892987-4E47E81D-6BBB-4F03-B0FA-E9CCDDDD22C7Q33974292-5BFCF57C-6FA4-4426-B512-9AB7B50B2136Q34161923-90BB08C5-6E6D-4BAF-B472-94825D1A4B57Q34217886-A7FC02EB-5F90-4EF1-AC27-6065C97A7BFCQ34331360-C9099FBA-2B5A-4EA3-97DA-36ECE61712D9Q34406177-90E33048-028D-4554-96E1-961C1D93633AQ34826982-3D5A4979-DAF0-4BB7-A9E4-4C77B981B456Q34874445-A2CF2874-6D7A-4A81-BCFB-D74AEB733C60Q34895613-733843F1-9B05-45A9-AB88-662C30077D48Q35097032-890EC9EB-F523-437D-A013-0A7C52786138Q35121601-48B2914A-A48D-4F86-980E-0C864E91B380Q35353193-8C43AD2F-DCC4-4D49-AC5A-AAF0E3ED1449Q35623744-49463C75-3799-42C1-9A1F-B50EF7B18A84Q35729708-E0528156-B0D8-4DDD-9367-681B6033D341Q35745699-5ABD7376-7B02-4F68-B9F1-C0D6C7B3517AQ35852431-0454ED05-86D8-45C5-BBFC-1EA2E135F149Q35919786-A2536B93-F2F6-45C2-AA74-27B8408C98F9
P2860
Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa.
@en
Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa.
@nl
type
label
Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa.
@en
Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa.
@nl
prefLabel
Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa.
@en
Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa.
@nl
P2093
P2860
P50
P356
P1476
Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa.
@en
P2093
Alex Chitani
Eduard E Zijlstra
Timothy E A Peto
Yasin Njalale
P2860
P304
P356
10.1056/NEJMOA065711
P407
P577
2007-12-01T00:00:00Z